CHABIOTECH CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17,010 KRW | -1.05% |
|
+0.65% | -13.17% |
| Jan. 08 | CHA Biotech to Partner with Subsidiary to Advance NK Cell Therapy | MT |
| 2023 | CHA Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Chabiotech Co.,Ltd. is a Korea-based company mainly engaged in the bio business. Along with its subsidiaries, the Company operates its business through two segments: bio segment and optical segment. Its bio segment engages in the provision of medical services; development of stem cells and cell therapy products; production of cosmetics and cosmetic raw materials; distribution of medical devices and others, as well as cord blood storage, health care services and others. Its optical segment engages in the manufacture of optical lenses, optical modules and other parts, which are used in mobile phone cameras.
Calendar
2024-05-09
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -13.17% | 697M | |
| +1.12% | 42.59B | |
| +6.77% | 40.65B | |
| +47.07% | 40.57B | |
| -11.96% | 26.77B | |
| +6.01% | 24.81B | |
| -24.92% | 18.17B | |
| -3.63% | 11.7B | |
| +27.16% | 12.05B | |
| +7.30% | 11.1B |
- Stock Market
- Equities
- A085660 Stock
- News Chabiotech Co.,Ltd.
- CHA Biotech : Unit Signs Contract with Sartorius for Viral Vectors Process Technology
